Clinical Trial Update: Drug Concentration Monitoring of Pembrolizumab in Non-Small Cell Lung Cancer Patients

View source ↗

Summary

A clinical trial update indicates that a study evaluating pembrolizumab drug concentration monitoring in patients with non-small cell lung cancer has been termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Oslo University Hospital | Conditions: NSCLC | Status: TERMINATED